HPV-16. Risk Assessment Status. Host. Host DNA. HPV-16 Risk Assessment Status. Medical Diagnostic Laboratories, L.L.C
|
|
- Phebe Perry
- 7 years ago
- Views:
Transcription
1 Episome HPV-16 Integration Risk Assessment Status HPV-16 Risk Assessment Status High-risk human papillomaviruses (HPV) are found in almost all cervical tumors and are therefore considered a causative factor of cervical cancer. However, most cervical intraepithelial lesions caused by high-risk HPV are known to spontaneously regress. This suggests that, although a causative factor, high-risk HPV infection does not independently cause cervical cancer. Therefore, it is important to consider additional factors or surrogate markers that play a role in the progression of premalignant cervical lesions. Many studies have identified HPV-related markers that can predict the progression of cervical intraepithelial lesions and cervical cancer. The markers include, but are not limited to, HPV type, HPV integration status, HPV viral load, and the HPV-16 genetic variant. HPV-16: INTEGRATION, VIRAL LOAD, AND CERVICAL CARCINOGENESIS Of the high-risk HPV types, HPV-16 is the prevalent genotype associated with approximately 20% of lowgrade cervical lesions, 50% of high-grade lesions and 60% of cervical squamous cell carcinomas. HPV-18 is prevalent in approximately 10% of cervical squamous cell carcinomas. Other HPV types (i.e., HPV-26, -31, -33, -35, -39, -45, -51, -52, -53, -56, -58, -59, -66, -68, -73, and -82) have less than a 10% prevalence in cervical squamous cell carcinomas. During its normal life cycle, the HPV-16 genome exists in a circular, or episomal state and upon infection of the basal cells of the squamous epithelium, remains distinct from the host genomic. The HPV-16 genome contains the viral oncogenes and E7, which encode proteins capable of immortalizing and transforming normal cells. The and E7 proteins interfere with host tumor suppressor genes p53 and prb, respectively. In the episomal state, the expression of and E7 are tightly regulated by a protein encoded by the viral gene. Cervical neoplastic progression requires the quantitative and spatial deregulation of and E7 expression, i.e., elevated and E7 expression throughout the epithelium as well as the basal epithelial cells. In approximately 80% of HPV-16 positive cervical carcinomas, a truncated viral genome which has integrated into the host genomic is found. The integration is correlated to elevated and E7 expression and confers a proliferative advantage to these cells, accounting for their clonal outgrowth. In cervical tumors where HPV-16 has integrated into the host, consistently the gene is completely or partially deleted. The loss of, which regulates and E7, allows for increased expression of the viral oncogenes. In addition, the integration leads to stability of the viral and E7 mrna transcripts, therefore increasing production of the two viral oncoproteins. Multiple clinical studies have shown that the episomal form of HPV-16 was mostly found in non-progression of preinvasive lesions, whereas the integrated form was found mostly in progression of preinvasive lesions. Thus, a decrease in the episomal form was associated with poorer outcome. In general, clinical studies in several countries show that the integration of HPV-16 is accompanied by an increase in the grade of cervical lesions and is strongly associated with persistent HPV infection and progression of cervical lesions. Only the episomal form of HPV-16 is capable of replicating and propagating the viral infection. Episomal replication may lead to a high viral load. Integrated HPV-16 is incapable of replicating. cells with integrated virus begin to expand and progress toward the cancerous state, while the episomal form is lost. HPV-16 infections are cleared more slowly than other HPV types and HPV-16 viral load has been reported as a marker for persistent HPV infection. HPV-16 viral load is also reported to be associated with high-grade cervical lesions and invasive cancer.
2 Recent clinical studies demonstrate that serial measurement of HPV-16 viral load may be a useful predictor for viral clearance and determining the outcome of viral infection. Normal CIN 1 CIN 2 CIN 3 Invasive Cancer Episome = Integration < Figure 1. The HPV-16 Viral Genome Status in Cervical Cancer. High-risk HPV infection Episomal replication High viral load Persistent infection Increased probability of integration deletions, elevated /E7 expression Selection of cell clones with integrated virus Cell cycle dysfunction, genetic aberrations CIN III Invasive cancer Figure 2. Hypothetical steps in HPV-associated cervical cancer progression. Adapted from Peitsaro et al. J Clin Microbiol. March 2002, 40(3): Sequencing of the HPV genome from clinical samples has identified many intratype variants. Those in the HPV-16 gene have been particularly well characterized and are used to identify HPV-16 variants. The first HPV-16 sequence was identified from a European woman and was termed the European prototype (EP). This sequence is used for comparison of all other HPV-16 sequences from clinical samples. Worldwide studies have identified several other major HPV-16 variants that are roughly grouped by geographic relationship. The European variants (EV) usually have one or two nucleotide differences from the EP. This group also includes an emerging variant, the Asian variant (As). One of the characteristic genetic changes of the EV commonly found in cervical cancer is T350G. The T350G change translates into an amino acid change in the HPV-16 protein. This altered protein has been shown to enhance the transformation of cervical cells more effectively than the protein from HPV-16 EP. A study of 354 US women found the HPV-16 EV to have a 1.6 odds ratio for risk of cervical cancer or CIN3 lesions compared to the EP. The major non-european variants are the African variants (AF-1 and AF-2), the North American variant (NA-1), and the Asian-American variant (AA). A study of 354 US women found the HPV-16 non- European variants collectively to have a 3.8 odds ratio for risk of cervical cancer or CIN3 lesions compared to the EP. Several worldwide studies have identified that the AA variant has a particularly high association with cervical cancer and CIN3 lesions with one study finding a 20- fold great association with invasive disease. Table 1. HPV-16 Variants: Grouping, Distribution, and Risk Result EP Variant Group European Prototype Distribution (est., US pop.) 45-50% Increased Risk HPV-16 Genetic Variation and Cervical Carcinogenesis EV(T350G), As European Variant 35-40% To understand the fact that only a minority of women infected with HPV-16 develop cervical cancer, there has been interest in the role of HPV sequence variation, and therefore HPV protein structure and function variation, in the progression of HPV-related cervical lesions. AF-1/2, NA-1 Non-European Variant 2-10% AA Non-European Variant 2-10% Abbreviations: EP, European prototype; EV(T350G), European variant (with T350G mutation); As, Asian variant; AF-1/2, African variants; NA-1, North American variant; AA, Asian-American variant.
3 HPV-16 Status Test For Integration, Viral Load, and Variant The sample is collected from the endocervix and ectocervix using the OneSwab specimen collection platform. The HPV-16 Status Test can also be performed on samples collected and placed in the ThinPrep solution. MDL offers the HPV-16 Status Test as a reflex for HPV Type-Detect samples that are HPV-16 positive ONLY. The HPV-16 Status Test combines information from two assays, one for integration and viral load and one for genotyping the variant. The HPV-16 integration and viral load assay uses quantitative Real-Time PCR to measure the number of copies of HPV-16, HPV-16, and human GAPDH genes within the cervical sample. The quantities of the two HPV-16 genes are compared in the / Ratio, which is an estimate of the Viral Integration Status (See Table 2). The quantities of the and GAPDH genes are compared in a copy number ratio (CNR), which is reported as Viral Load (viral genome copies/human genome). Table 2. How the / Ratio Relates to HPV-16 Integration Status / Ratio Viral Status 0.8 Episomal 0.2 and < 0.8 Mixed < 0.2 Integrated The HPV-16 variant assay uses PCR and multiplex allele specific primer extension (ASPE) to identify specific changes at 12 positions of the HPV-16 gene and determine the variant. Advantages of the HPV-16 Status Test Unique molecular testing that supplements the information provided by HPV Type-Detect providing an integrated view of four factors reported to be associated with the development of HPV-16-related cervical dysplasia and cervical cancer. The Real-Time PCR method is sensitive and specific and is capable of accurately quantifying the copies of HPV-16, HPV-16, and human GAPDH genes present in OneSwab and ThinPrep samples. The PCR and ASPE method is sensitive and can specifically identify known nucleotide changes at multiple positions in the HPV-16 gene, rapidly identifying HPV-16 variants. Provided and supported by Oncoveda Cancer Research Center, established by Medical Diagnostic Laboratories, L.L.C. to translate cancer research into diagnostic tools. References 1. Cricca M, et al., Viral load, physical status and / ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol, 106(3): Cullen AP, et al., Analysis of the physical state of different human papillomavirus s in intraepithelial and invasive cervical neoplasm. J Virol, 65(2): Dalstein V, et al., Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 106(3): Hudelist G, et al., Physical state and expression of HPV in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol, 92(3): Kulmala SM, et al., Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol, 59(5): Li W, et al., The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol, 134(12): Lorincz AT, et al., Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet, 360(9328): Marks M, et al., Kinetics of load predict HPV 16 viral clearance. J Clin Virol, 51(1): Melsheimer P, et al., aneuploidy and integration of human papillomavirus type 16 /E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res. 10(9): Moberg M, et al., Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer. 112(5):854-9.
4 11. Monnier-Benoit S, et al., Dynamics of HPV16 load reflect the natural history of cervical HPV-associated lesions. J Clin Virol, 35(3): Peitsaro P, et al., Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol, 40(3): Pett M, et al., Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol, 212(4): Pirami L, et al., Analysis of HPV16, 18, 31, and 35 in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol 50(7): Ramanakumar AV, et al., Human papillomavirus (HPV) types 16, 18, 31, 45 loads and HPV-16 integration in persistent and transient infections in young women. BMC Infec Dis. 10: Saunier M, et al., Analysis of human papillomavirus type 16 (HPV16) load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clinical Microbiol. 46(11): van Duin M, et al., Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer. 98(4): Wanram S, et al., The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. Am J Obstet Gynecol, 201(1):79 e Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sällström J, Wilander E Uneven distribution of HPV 16 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer, 83: Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I Increased risk for cervical disease progression of French women infected with the human papillomavirus type G variant. Cancer Epidemiol Biomarkers Prev, 15: Richard C, Lanner C, Naryzhny SN, Sherman L, Lee H, Lambert PF, Zehbe I The immortalizing and transforming ability of two common human papillomavirus 16 variants with different prevalences in cervical cancer. Oncogene, 29: Stöppler MC, Ching K, Stöppler H, Clancy K, Schlegel R, Icenogle J Natural variants of the human papillomavirus type 16 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 70: Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER Human papillomavirus type 16 and /E7 variants. Gynecol Oncol, 96: Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Paolo G, Franceschi S, Buonaguro FM Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol, 74: Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 71: Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev, 16: Zehbe I, Wilander E, Delius H, Tommasino M Human papillomavirus 16 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res, 58: Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T Association of HPV16 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer, 125(11):
5
HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer
Revolutionizing healthcare one cell at a time HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer Numerous studies confirm that the presence of HR HPV DNA
More informationCXCA-MSP. The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics. www.gbo.
CXCA-MSP The next step in cervical cancer prevention! GynTect : Epigenetic biomarkers for reliable cancer diagnostics www.gbo.com/diagnostics H 3 C NH 2 NH H 3 C 2 N mc N mc N H N O H O The challenge of
More informationNATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME
NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME CERVICAL CANCER Introduction Cancer of the cervix is the second most common form of cancer amongst South African women. Approximately one in every
More informationHUMAN PAPILLOMAVIRUS (HPV) FACT SHEET
HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET Background Information - Human Papillomavirus HPV is the name of a group of viruses that include more than 80 different types associated with a variety of epidermal
More informationGenital Human Papillomavirus. Patti E. Gravitt, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationGLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET
GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET When detected, HPV infection is easily managed and rarely proceeds to cancer Very few women with HPV develop cervical cancer HPV infections are only one of
More informationIMMEDIATE HOT LINE: Effective March 2, 2015
MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only
More informationExplanation of your PAP smear
Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,
More informationOral HPV: An Overview of the Infection and its Role in the Development of Oral Cancer
Oral HPV: An Overview of the Infection and its Role in the Development of Oral Cancer PL-000238-A 7400 Flying Cloud Drive / Eden Prairie, MN 55347 855-ORALDNA (672-5362) / Fax: 952-942-0703 / OralDNA.com
More informationHuman papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Int. J. Cancer: 121, 621 632 (2007) ' 2007 Wiley-Liss, Inc. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update Jennifer S. Smith
More informationPap smears, cytology and CCHC lab work and follow up
Pap smears, cytology and CCHC lab work and follow up What is a Pap Smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the
More informationHUMAN PAPILLOMAVIRUS (HPV) TESTING
MEDICAL POLICY HUMAN PAPILLOMAVIRUS (HPV) TESTING Policy Number: CDP - 041 Effective Date: October 1, 2014 Table of Contents Page BACKGROUND 1 POLICY 3 REFERENCES 5 POLICY HISTORY/REVISION HISTORY 7 INSTRUCTIONS
More informationThe pathogenesis of human Papillomavirus (HPV) in the development of cervical cancer: are HPV vaccines a safe and effective management strategy?
University of Wollongong Research Online Faculty of Law, Humanities and the Arts - Papers Faculty of Law, Humanities and the Arts 2011 The pathogenesis of human Papillomavirus (HPV) in the development
More informationMUTATION, DNA REPAIR AND CANCER
MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful
More informationCervical Cancer Screening Guideline
Cervical Cancer Screening Guideline Prevention 2 Abbreviations Used 2 Specimen Collection Techniques 3 Screening 4 Management Women 21 Years and Older Pap results 5 findings: ASC-US and LSIL 6 findings:
More informationHuman papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency viruspositive
Journal of General Virology (2008), 89, 1380 1389 DOI 10.1099/vir.0.83553-0 Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency viruspositive Italian women Maria Lina Tornesello,
More informationCervical Cancer The Importance of Cervical Screening and Vaccination
Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this
More informationHPV DNA-Chip. PapilloCheck HPV-Screening. DNA-Chip for the genotyping of 24 types of genital HPV
HPV DNA-Chip PapilloCheck HPV-Screening DNA-Chip for the genotyping of 24 types of genital HPV PapilloCheck : fast and reliable PapilloCheck at a glance: Complete kit with DNA-arrays and solutions for
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationHuman Papillomavirus Type 16 Status in Cervical Carcinoma Cell DNA Assayed by Multiplex PCR
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2003, p. 608 612 Vol. 41, No. 2 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.2.608 612.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Human
More informationCervical Cancer Prevention in Saudi Arabia: It is Time to Call for Action!
The Open Women s Health Journal, 2012, 6, 1-5 1 Open Access Cervical Cancer Prevention in Saudi Arabia: It is Time to Call for Action! Khalid Sait 1, James Bentley 2, Nisrin Anfinan*,1 and Patti Power
More informationCancer of the Cervix
Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationPROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor
1 ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor Cervical cytology screening has significantly decreased rates of mortality from cervical cancer; however, 400 women die each year
More informationHuman Papilloma Virus and HPV vaccine knowledge among Mustafa Kemal University Medical Students
Acta Medica Anatolia Volume 2 Issue 2 2014 Human Papilloma Virus and HPV vaccine knowledge among Mustafa Kemal University Medical Students Raziye Keskin Kurt 1, Atilla Karateke 1, Mehmet Erdem 2, Dilek
More informationLDMAS (LOH Data Management and Analysis Software) User Guide
LDMAS (LOH Data Management and Analysis Software) User Guide Written by : Rifat Hamoudi, Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, CB2 2QQ. Email
More informationManagement of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference
Management of Abnormal PAP Smears K Chacko, MD, FACP 2010 GIM Conference Scope of the Problem About 7-10% 7 of PAPs will come back abnormal 3.5 to 4 million in the US each year Approximate 4000 deaths
More informationNational Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28) Tracking Information Publication Number Manual Section Number 100-3 190.28 Manual Section Title Tumor Antigen by
More informationHuman Papillomavirus Infection and Oropharyngeal Cancer
Human Papillomavirus Infection and Oropharyngeal Cancer Robert I. Haddad, MD Introduction Squamous cell carcinoma of the head and neck (SCCHN), which affects close to 40,000 individuals each year in the
More informationManagement of Abnormal Pap Smear Clinical Practice Guideline
Management of Abnormal Pap Smear Clinical Guideline General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method
More informationTesting for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology
67 Testing for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology Positive Rates in Equivocal and Abnormal Specimens and Comparison With the ASCUS to SIL Ratio Vincent Ko, MD Shabin
More informationPART 3.3: MicroRNA and Cancer
BIBM 2010 Tutorial: Epigenomics and Cancer PART 3.3: MicroRNA and Cancer Dec 18, 2010 Sun Kim at Indiana University Outline of Part 3.3 Background on microrna Role of microrna in cancer MicroRNA pathway
More informationHPV testing in the follow-up of women post colposcopy treatment
HPV testing in the follow-up of women post colposcopy treatment Contents Background 2 Treatment of CIN and risk of recurrence 2 The natural history of HPV infections 2 HPV testing for women following
More informationHPV, Oral Cancer, and the LGBT Community By Jennifer Moon
HPV, Oral Cancer, and the LGBT Community By Jennifer Moon Many people in the LGBT community don t know that oral cancer can be caused by the human papilloma virus (HPV) the most common sexually transmitted
More information<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012
More information
Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base
Mutations Mutations: 2 general ways to alter DNA Change a single DNA base Or entire sections of DNA can move from one place to another What is a mutation? Any change in the nucleotide sequence of DNA Here
More informationGenetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2)
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationCervical Cancer. Shannon Bartley Liliya
Cervical Cancer Shannon Bartley Liliya The quality of life turned to be better than before. Nowadays people live in better conditions. They eat high quality food and receive all vitamins needed for health.
More informationmicrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved
microrna 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions of target mrnas Act as negative
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationREAL TIME PCR SYBR GREEN
REAL TIME PCR SYBR GREEN 1 THE PROBLEM NEED TO QUANTITATE DIFFERENCES IN mrna EXPRESSION SMALL AMOUNTS OF mrna LASER CAPTURE SMALL AMOUNTS OF TISSUE PRIMARY CELLS PRECIOUS REAGENTS 2 THE PROBLEM QUANTITATION
More informationWhat is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
More informationHPV Type-Detect 2.0. by Bio-Plex Analysis. The Next Generation of HPV Diagnostics. Medical Diagnostic Laboratories, L.L.C. www.mdlab.com 877.269.
HPV Type-Detect 2.0 by Bio-Plex Analysis The Next Generation of HPV Diagnostics Medical Diagnostic Laboratories, L.L.C. www.mdlab.com 877.269.0090 Medical Diagnostic Laboratories, L.L.C. Papillomaviruses
More informationIntroduction to Pathology and Diagnostic Medicine
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Introduction to Pathology and Diagnostic Medicine Spring 2003 What is pathology?
More informationRegulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)
Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci
More informationThe Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
More informationHUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER: PATHOGENESIS AND EPIDEMIOLOGY
HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER: PATHOGENESIS AND EPIDEMIOLOGY Daniel Tena Gómez 1 and Juana López Santos 2. 1 Section of Microbiology. 2 Service of Clinical Analysis. University Hospital
More informationHPV vaccines. Ian H. Frazer CHAPTER 8. 1. Introduction. KEYWORDS Cervical cancer; Vaccination; Human papillomavirus
International Journal of Gynecology and Obstetrics (2006) 94 (Supplement 1), S81 -S88 www.elsevier.com/locate/ijgo CHAPTER 8 HPV vaccines Ian H. Frazer KEYWORDS Cervical cancer; Vaccination; Human papillomavirus
More informationXI International Workshop of Lower Genital Tract Pathology HPV Disease: The global battle Rome 19-21 April 2012
XI International Workshop of Lower Genital Tract Pathology HPV Disease: The global battle Rome 19-21 April 2012 Thursday 19 nd April 2012 Morning Sessions 07.50-08.20 Registration 08.20-08.40 Welcome:
More informationThe Cervical Screening Manual
The Cervical Screening Manual A Guide for Health Departments and Providers Collaboration Partners: Chronic Disease and Injury Section Breast and Cervical Cancer Control Program Women s and Children s Health
More informationALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
More informationDr Julia Palmer BAC Annual Scientific Meeting October 2015 THE IMPACT OF HPV PRIMARY SCREENING ON COLPOSCOPY.
Dr Julia Palmer BAC Annual Scientific Meeting October 2015 THE IMPACT OF HPV PRIMARY SCREENING ON COLPOSCOPY. Aims: An evaluation of primary HPV screening commenced in Sheffield in May 2013. This lecture
More informationAmerican Academy of Family Physicians
American Academy of Family Physicians Barbara E. Stanford MD Grand Rapids Family Medicine Residency Wege Family Medicine HPV is transient in most women HPV-75% Normal ASCUS LSIL HSIL Cancer 80-90% 75%???
More informationThe human papillomavirus vaccine
The human papillomavirus vaccine The virus, the diseases and the HPV vaccine Beating cervical cancer the facts This factsheet describes the human papillomavirus (HPV), the diseases that it causes and the
More informationA Zaal a,b, JA Louwers b,c, J Berkhof d, M Kocken b,e, FJ van Kemenade b, RHM Verheijen a
Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy A Zaal a,b, JA Louwers
More informationPolyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1
Course AP104 Endometrial Hyperplasia A morphologic Definition Hyperplasias Hormonal Effect or Precancer? George L. Mutter, MD Harvard Medical School and Brigham and Women s Hospital Boston, MA Endometrial
More informationCervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University
Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Burden of HPV related cancers l l Cervical Cancer of the cervix
More informationCervical cancer screening: What s new and what s coming?
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will adhere to current guidelines for screening for cervical cancer Xian Wen Jin, MD, PhD, FACP* Department of Internal Medicine, Cleveland Clinic; Assistant
More informationRoutine Vaginal Cuff Smear Testing in Post Hysterectomy Patients With Benign Uterine Conditions: When Is It Indicated?
ORIGINAL ARTICLES Routine Vaginal Cuff Smear Testing in Post Hysterectomy Patients With Benign Uterine Conditions: When Is It Indicated? Andrea Videleftky, MD, Nonnan GrossI, MD, Maxine Denniston, MSPH,
More informationPredominance of ERG negative high grade prostate cancers in African American men
982 Predominance of ERG negative high grade prostate cancers in African American men JAMES FARRELL 1,2, DENISE YOUNG 1, YONGMEI CHEN 1, JENNIFER CULLEN 1, INGER L. ROSNER 1,2, JACOB KAGAN 3, SUDHIR SRIVASTAVA
More informationThe RNA strategy. RNA as a tool and target in human disease diagnosis and therapy.
The RNA strategy RNA as a tool and target in human disease diagnosis and therapy. The Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology (CIBIO) of the University of Trento,
More information2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors L. Stewart Massad, MD, Mark H. Einstein, MD, Warner K. Huh, MD, Hormuzd A. Katki,
More informationSickle cell anemia: Altered beta chain Single AA change (#6 Glu to Val) Consequence: Protein polymerizes Change in RBC shape ---> phenotypes
Protein Structure Polypeptide: Protein: Therefore: Example: Single chain of amino acids 1 or more polypeptide chains All polypeptides are proteins Some proteins contain >1 polypeptide Hemoglobin (O 2 binding
More informationGUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015
GUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015 Cervical cancer remains an important cause of morbidity and mortality in South Africa. At present the national cervical cancer prevention
More informationRisk assessment of cervical disease by hrhpv testing and cytology Thesis, Erasmus University Rotterdam, The Netherlands
R I S K A S S E S S M E N T O F C E R V I C A L D I S E A S E BY h r H P V T E S T I N G A N D C Y TO LO G Y M a r i ë l l e K o c k e n Risk assessment of cervical disease by hrhpv testing and cytology
More informationTransfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.
Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,
More information92-0200. An in vitro diagnostic test for the detection of DNA from Human Papillomavirus (HPV) Type 16 and Type 18 in Cervical Specimens.
Cervista HPV 16/18 92-0200 An in vitro diagnostic test for the detection of DNA from Human Papillomavirus (HPV) Type 16 and Type 18 in Cervical Specimens. -30 C -15 C In vitro diagnostic medical device
More informationworry When to Cervical Abnormalities CME Workshop What s the situation? What are the trends? By Dianne Miller, MD, FRCSC In this article:
CME Workshop When to worry Cervical Abnormalities By Dianne Miller, MD, FRCSC What s the situation? Over 600,000 Papanicolaou s (Pap) smears were performed in British Columbia in 2000. Approximately 13,400
More informationLiquid-based cytology
Liquid-based cytology Claire Bourgain UZBrussel Introduction LBC for gynaecological cytology has been introduced in Belgium a decade ago There is no consensus On performance compared to conventional cytology
More informationHow To Make An Antibody Against Human Papillomavirus (Hpv)
Maria Lidqvist Department of Microbiology and Immunology Institute of Biomedicine Sahlgrenska Academy at University of Gothenburg Gothenburg 2012 Monoclonal antibodies against human papillomavirus E7 oncoprotein
More informationVaginal Swab Measurement of Human Papillomavirus in Wave I of the Social Life Health & Aging Project
Human Papillomavirus (HPV) Vaginal Swab Measurement of Human Papillomavirus in Wave I of the Social Life Health & Aging Project Authors: Stacy Tessler Lindau, MD, MAPP, University of Chicago, Departments
More informationProtocol for an integrated data request of test results from the laboratories of pathological anatomy. SNOMED 3.5VF - users version January 2016
Protocol for an integrated data request of test results from the laboratories of pathological anatomy SNOMED 3.5VF - users version January 2016 Cancer diagnoses & early detection of cancer (breast, colorectal
More informationEpidemiology of Human Papillomavirus Infection and Abnormal Cytologic Test Results in an Urban Adolescent Population
BRIEF REPORT Epidemiology of Human Papillomavirus Infection and Abnormal Cytologic Test Results in an Urban Adolescent Population Trudee A. Tarkowski, 1,a Emilia H. Koumans, 2 Mary Sawyer, 3 Antonya Pierce,
More informationChapter 1: HPV in the etiology of human cancer
Vaccine 24S3 (2006) S3/1 S3/10 Chapter 1: HPV in the etiology of human cancer Nubia Muñoz a,, Xavier Castellsagué b, Amy Berrington de González c, Lutz Gissmann d a Institut Català d Oncologia (ICO), 24,
More informationInnersense Voice 139 Jan 15, 2013 Screen to Prevent: Cervical & Prostate Cancer
Screening test to detect cancer at its earliest stage has been one of the most studied areas in our fight against cancer. However, the benefits of screening in terms of cancer prevention, early detection
More informationLiver Disease and Therapy of Hepatitis B Virus Infections
Liver Disease and Therapy of Hepatitis B Virus Infections University of Adelaide Catherine Scougall Arend Grosse Huey-Chi Low Allison Jilbert Fox Chase Cancer Center Chunxiao Xu Carol Aldrich Sam Litwin
More informationHPV, Cervical Dysplasia and Cancer
FACTSHEET HPV, Cervical Dysplasia and Cancer Summary Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions by doctors, may persist and
More informationSkin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.
Skin Cancer: The Facts Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Types of skin Cancer Basal cell carcinoma (BCC) most common
More informationLaboratory Methods for Detection. of Human Papillomavirus Infection
Laboratory Methods for Detection of Human Papillomavirus Infection Luisa Lina Villa Contents.1 Introduction... 3. HPV DNA Methods... 4.3 HPV RNA Methods... 6.4 Serological Assays... 7.5 Detecting HPV Infection
More information1 Mutation and Genetic Change
CHAPTER 14 1 Mutation and Genetic Change SECTION Genes in Action KEY IDEAS As you read this section, keep these questions in mind: What is the origin of genetic differences among organisms? What kinds
More informationIKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics
Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex
More informationAccent on Health Obgyn, PC HPV Frequently Asked Questions
1. What is HPV? 2. How do you get HPV? 3. How common is HPV? 4. What are the symptoms of HPV? 5. Can HPV be treated? 6. What is the HPV test and how is it different from a PAP test? 7. Can the HPV test
More informationCancer screening: cost-effectiveness. Endoscopic polypectomy: : CRC mortality. Endoscopic polypectomy: : CRC incidence
Cribado del cáncer (colorrectal): las pruebas de detección precoz salvan vidas Dr. Antoni Castells Servicio de Gastroenterología Hospital Clínic nic,, Barcelona (castells@clinic.cat) Conditions for a population-based
More informationThe sequence of bases on the mrna is a code that determines the sequence of amino acids in the polypeptide being synthesized:
Module 3F Protein Synthesis So far in this unit, we have examined: How genes are transmitted from one generation to the next Where genes are located What genes are made of How genes are replicated How
More informationTitle: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
Author's response to reviews Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma Authors: Tanner L Bartholow (bartholow.tanner@medstudent.pitt.edu) Uma R Chandran (chandranur@msx.upmc.edu)
More informationBreast cancer and the role of low penetrance alleles: a focus on ATM gene
Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1
More informationIntroduction To Real Time Quantitative PCR (qpcr)
Introduction To Real Time Quantitative PCR (qpcr) SABiosciences, A QIAGEN Company www.sabiosciences.com The Seminar Topics The advantages of qpcr versus conventional PCR Work flow & applications Factors
More informationThe Pap Smear: Guidelines for Screening and Follow-up
The Pap Smear: Guidelines for Screening and Follow-up The incidence of and mortality from cervical cancers have decreased with the Pap smear's opportunistic use in Canada. The rate of decline has eased,
More informationRisk Factors for Alcoholism among Taiwanese Aborigines
Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social
More informationHPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings. Curt Malloy, M.S.
HPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings Curt Malloy, M.S. Jacqueline Sherris, Ph.D. Cristina Herdman Preparation of this paper was supported
More informationPCOS Poly Cystic Ovarian Syndrome and Gardasil Prepared by Leslie Carol Botha April 15, 2011
PCOS Poly Cystic Ovarian Syndrome and Gardasil Prepared by Leslie Carol Botha April 15, 2011 Polycystic ovarian syndrome (PCOS) is a disorder characterized by laboratory and/or clinical findings of higher
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS
More informationCervical Cancer Screening and Management Guidelines: Changing Again, Huh?
Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Summary of 2013 recommendations from ASC (American Cancer Society), ASCCP (American Society for Colposcopy and Cervical Pathology),
More informationHuman Papillomavirus and Cervical Cancer
ORIGINAL ARTICLE Human Papillomavirus and Cervical Cancer Current Status of Vaccination Against Human Pathogenic Papillomavirus Martin Löning, Lutz Gissmann, Klaus Diedrich, Klaus Friese, Rolf Kreienberg,
More informationData Analysis for Ion Torrent Sequencing
IFU022 v140202 Research Use Only Instructions For Use Part III Data Analysis for Ion Torrent Sequencing MANUFACTURER: Multiplicom N.V. Galileilaan 18 2845 Niel Belgium Revision date: August 21, 2014 Page
More informationEffects of Herceptin on circulating tumor cells in HER2 positive early breast cancer
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine
More informationSpecimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
More informationQuantitative HBV DNA measurements and the management of infected health care workers
Quantitative HBV DNA measurements and the management of infected health care workers A.A. van der Eijk Department of Virology, Erasmus MC, Rotterdam, the Netherlands Introduction Worldwide since 1970s,
More informationInterpretation Guide for Ventana INFORM HPV Probes In Situ Hybridization (ISH) Staining of Cervical Tissue
Interpretation Guide for Ventana INFORM HPV Probes In Situ Hybridization (ISH) Staining of Cervical Tissue Thomas M. Grogan, M.D. Hiro Nitta, Ph.D. Lidija Pestic-Dragovich, Ph.D. Lizhen Pang, M.S. Jay
More informationEuropean Medicines Agency
European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein
More information